Literature DB >> 5424526

Urinary excreion of DOPA and metabolites by patients with melanoma.

M L Voorhess.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 5424526     DOI： 10.1002/1097-0142(197007)26:1<146::aid-cncr2820260119>3.0.co;2-4

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  4 in total

1.  A case of dark urine, hyperpigmentation and hepatomegaly.

Authors:  B M McClements; I F McDowell; D R McCluskey
Journal:  Ir J Med Sci       Date:  1988-05       Impact factor: 1.568

2.  Tomographic gallium-67 citrate scanning. Useful new surveillance for metastatic melanoma.

Authors:  J M Kirkwood; J E Myers; D R Vlock; R Neumann; S Ariyan; A Gottschalk; P Hoffer
Journal:  Ann Surg       Date:  1983-07       Impact factor: 12.969

3.  Neural network approach to detection of metastatic melanoma from chromatographic analysis of urine.

Authors:  M E Cohen; D L Hudson; P W Banda; M S Blois
Journal:  Proc Annu Symp Comput Appl Med Care       Date:  1991

4.  Determination of 5-S-cysteinyldopa in melanomas with a fluorimetric method.

Authors:  H Rorsman; A M Rosengren; E Rosengren
Journal:  Yale J Biol Med       Date:  1973-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.